abuses of those in power to take your liberty, your property, your reputation, and, inin deed, your life. he promised a humility so often found with the powerful embrace fairness as their foundation. it sure doesn t seem that way, does it? gary sappily is a supervisory special agent for the irs where he s worked for 14 years. in january 2020, he was assigned to what he calls a high profile investigation. who s the subject of the investigation? i can t confirm or deny the subject of this investigation. why not. because part of the tax secrecy laws don t allow it. he can t say it but cbs news learned the investigation was the probe of hunter biden by the trump-appointed us attorney if delaware. cbs news has obtained this letter his lawyer sent to congress monday alleging irregularities in doj s handling of the investigation. schapley is seeking legal protections from congress so he can share specifics of his allegations. there were multiple steps that were slow-wa
local bacteria that we insert into the bladder. that s now great shortage. you know what we have to do? we have to give more powerful, more poisonous chemo therapies to patients that we would give that treatment for if we could get it. government. trey: sounds like it is economics, not supply chains, not government regulations it s the economics of where drug companies can make money or is that a simple minded way of looking at it. you are naefr simple minded that is exactly right. i will a put it another way. we have so much exposure in the media about greedy drug companies we lost the headlines. we re 300 drugs short right now, huge numbers. but it s generics. generics stay out of the headlines they don t get the headlines. we talk about drugs, adderall, but not chemotherapy or intravenous drugs because janer i cans make them. they don t make money. they don t make the same kind of
chemotherapy as well as maybe other organs in the body? another excellent point. there s something call blood brain barrier and a lot of chemo therapies may not get to that part. that s absolutely right. that s why, surgery, if it can be receptive and your first surgery is the best chance that you have in getting margins, removing the entire cancer sometimes, depending on the location of these brain cancers, it s so hard to get to them because by removing a lot more you may paralyze somebody you may affect someone s speech. you may cause visual disturbances. the surgeon is working in a very narrow space, a difficult cancer and you want to remove as much as you can without affecting any kind of paralysis or motor or speech kind of defects. it s hard to imagine anything scarier. unfortunately, with a lot of brain cancers, it s almost a death sentence and we re not really there when it comes to good prognosis. but some folks do.
we prove the therapies to be safe and effective for patients and we have to go through the fda and there may be room for improvement in the fda process as well. nsomething else that the doctor talked about. it is more mutation than location. and the thought that if you have lung cancer that is a specific type of treatment. and it may not be the location of where your particular cancer crops up? exactly. what he is suggesting that if you have a particular mutation that causes a cancer in the gi track that responds like a lung cancer mutation. it may be reasonable to trial a lung cancer drug. it is a combination of efforts not only genetics but the standard chemo therapies and putting that together to provide
enough research to figure how to cure it. it was devastating. i have battled six major abdomenal surgeris and 10 different chind of chemo therapies and my husband and i did research. we realize that rare cancers are more common than you think. they are 50 percent of all cancer cases a year. establish establish and so doctor, if 50 percent of the cancers of the world are considered rare, it is because big pharmesutical companies are trying to attend to ones that more people have. there is a market for larger tumor types and mauler ones don t get the attention. yet they constitute 50 percent of all cancers in the united states. that is a huge number when you put them altogether. she has a carcomraand gall bladder and tomac and pancreas . tumors and goes on and on and